台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
旭富 (4119)籌碼相關-中國信託-三重 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

中國信託-三重 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1600.000.184.1084.00-0.1271-0.02%
2024/12/2500.00189.9090.00-1248-0.40%
2024/12/2400.002.190.2089.90-2.1248-0.82%
2024/12/170.190.7000.0090.200.12430.02%
2024/11/2600.00196.4095.50-1193-0.52%
2024/11/2100.00697.5898.00-6178-3.36%
2024/11/20998.36497.4597.8051722.89%
2024/11/1500.00295.1095.50-2147-1.36%
2024/11/0100.00190.0090.00-1114-0.87%
2024/10/0700.00392.0092.20-3135-2.21%
2024/09/060.487.4000.0086.500.41590.25%
2024/09/05187.0000.0086.5011600.62%
2024/08/30188.0000.0088.4011710.58%
2024/08/19188.9000.0089.0011840.54%
2024/08/16289.0000.0089.3021861.07%
2024/08/130.289.9000.0089.500.21980.12%
2024/08/08290.5000.0090.2022040.98%
2024/07/220.390.5000.0090.800.32020.15%
2024/07/180.192.2000.0092.700.11990.03%
2024/07/05191.1000.0091.3012030.49%
2024/06/0600.00193.5092.40-1218-0.46%
2024/05/2700.00193.1093.10-1234-0.43%
2024/05/240.291.7000.0091.900.22330.08%
2024/05/2300.00191.4091.30-1235-0.42%
2024/05/2100.000.192.4092.10-0.1235-0.04%
2024/05/17193.80293.7593.90-1230-0.43%
2024/05/1600.003.292.2092.50-3.2225-1.42%
2024/05/1300.00192.0091.80-1232-0.43%
2024/05/10191.00490.4890.90-3240-1.25%
2024/05/0800.00188.8088.80-1242-0.41%
2024/04/22286.4000.0086.5022540.79%
2024/04/19386.7700.0086.4032541.18%
2024/03/27187.8000.0087.5012590.38%
2024/03/26187.2000.0087.2012600.38%
2024/03/14487.2800.0087.2042861.40%
2024/03/13487.8000.0087.9042851.40%
2024/03/12189.0000.0089.0012780.36%
2024/03/11289.2500.0089.1022750.73%
2024/03/080.190.7000.0090.400.12730.04%
2024/03/07390.9000.0090.5032691.11%
2024/02/21191.2000.0091.2012830.35%
2024/02/200.591.4600.0091.000.52840.18%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章